In this video

Share

Amarin CEO on FDA's approval of key heart drug

Amarin CEO and president John Thero joins CNBC's "Power Lunch" team to discuss the drug company's FDA approval for Vascepa, a drug designed to reduce the incidence of heart attacks and strokes in high-risk patients. Amarin boosted its 2020 financial outlook following news of the approval.
04:36
Mon, Dec 16 20192:57 PM EST